Radiopharmaceutical Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025- Increase in the prevalence of cancer and increased used of medical imaging as a diagnostics procedure is likely to grow the radiopharmaceutical market.
Radiopharmaceutical Market is valued at USD 5433.2 Million in 2018 and expected to reach USD 7956.1 Million by 2025 with the CAGR of 5.6% over the forecast period.
Radiopharmaceuticals are the pharmaceutical agents which contains radioactive materials used for therapeutic or diagnostic procedure. These radioactive materials are mostly radioisotopes which emits the gamma radiation of short wavelength which can destroy the cells. These radiopharmaceuticals are mostly used for the cancer cell destruction, arthritis and treatment for pain. Radiopharmaceuticals are used in various diagnostic procedures, nuclear medicine mostly in medical imaging. One of the major divisions of radiopharmaceuticals is contributed by radiotracers which are used in medical imaging to diagnose any dysfunction in tissues. Around 5-8 years is the typical duration which these radiopharmaceuticals take for the launch in the market and human use.
Get Sample Copy of This Premium Report @ https://brandessenceresearch.biz/Request/Sample?ResearchPostId=67366&RequestType=Sample
Radiopharmaceutical Market report is segmented on type, end user, application and by regional & country level. Based upon type, radiopharmaceutical market is segmented into Diagnostic Radiopharmaceuticals and Therapeutic radiopharmaceuticals. On the basis of end user, the market is segmented into Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, and Others. Based upon application, radiopharmaceutical market is classified into Cardiology, Neurology, Oncology, and Other.
The regions covered in this Radiopharmaceutical market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of Radiopharmaceutical market is sub divided into U.S., Mexico, Canada, UK, France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.
Key Players for Radiopharmaceutical Market Reports–
Some major key players for Radiopharmaceutical market are Cardinal Health, Inc., Eczacibasi-Monrol Nuclear Products, GE Healthcare, Bracco Imaging S.p.A, Nordion, Inc., Bayer Healthcare, Advanced Accelerator Applications S.A., IBA Molecular Imaging, Lantheus Medical Imaging, Inc., Jubilant Pharma, Mallinckrodt plc, and Siemens Healthcare among others.
News–
In April 2018, BWX Technologies, Inc. has announced that it has signed a definitive agreement to acquire Sotera Health’s Nordion medical isotope business. The acquisition accelerates and de-risks BWXT’s entry into the medical radioisotope market by adding licensed infrastructure, approximately 150 highly trained and experienced personnel, and two production centers to BWXT.
Request for Methodology @ https://brandessenceresearch.biz/Request/Sample?ResearchPostId=67366&RequestType=Methodology
Increase in the prevalence of cancer and increased used of medical imaging as a diagnostics procedure is the key factor which helps Radiopharmaceutical Market to grow.
There has been tremendous growth in the prevalence of various chronic disorders such as cancer, cardiovascular disorders and others has fueled the growth of radiopharmaceutical market. As per Research UK report, there were around 17 million new cases of cancer has been reported in 2018. As the prevalence of chronic disorders has increased it has also increased the demand for better and accurate diagnosis for better treatment. This in turn has increase the use of medical imaging on a large scale which involves the use of radiopharmaceuticals as a tracer to detect the dysfunction tissue in the body. Moreover, there drugs are useful for the better and pain relieving treatment in chronic disorders, further development in the radiopharmaceuticals are expected to contribute the growth of radiopharmaceutical market over the forecast period. The increase in research and development activities with technological advancement and strategic alliances in the market are expected to create ample opportunities in the radiopharmaceuticals market. However, mishandling during the manufacturing process and high cost of radiopharmaceuticals are expected to hamper the growth of radiopharmaceuticals market.
North America is expected to dominate the Radiopharmaceutical Market.
North America is expected to account for the major market share and expected to dominate the market over the forecast period. Due to the presence of developed countries such as U.S., Canada and others coupled with increased prevalence of cancer and medical imaging and increased public awareness. Europe is expected to closely follow North America in terms of market share due to the presence of advanced infrastructure, increase in research & development and technological advancement are expected to promote the growth of radiopharmaceutical market over the forecast period. Asia Pacific is expected to develop significantly in terms of growth rate and maintain its dominance over the forecast period. Increased adoption of advanced technology, increased prevalence of chronic disorders, increase in public awareness, increase in disposable income and others factors are expected to promote the growth of radiopharmaceutical market. Latin America, Africa and Middle East is expected to develop moderately in the near future.
Key Benefits for Radiopharmaceutical Market Reports –
Global market report covers in depth historical and forecast analysis.
Global market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
Global market report helps to identify opportunities in market place.
Global market report covers extensive analysis of emerging trends and competitive landscape.
Get Full information of This Report @ https://brandessenceresearch.biz/Medical-Devices-and-Consumables/Radiopharmaceutical-Market-Share/Summary
Radiopharmaceutical Market Segmentation –
By Type
Diagnostic Radiopharmaceuticals
Therapeutic radiopharmaceuticals
By End User
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Others
By Application
Cardiology
Neurology
Oncology
Other
By Regional & Country Analysis:
North America
U.S.
Canada
Europe
U.K.
France
Germany
Italy
Asia Pacific
China
Japan
India
Southeast Asia
Latin America
Brazil
Mexico
Middle East and Africa
GCC
Africa
Rest of Middle East and Africa
Table of Content
1. Chapter – Report Methodology
1.1. Research Process
1.2. Primary Research
1.3. Secondary Research
1.4. Market Size Estimates
1.5. Data Triangulation
1.6. Forecast Model
1.7. USP’s of Report
1.8. Report Description
2. Chapter – Global Radiopharmaceutical Market Overview: Qualitative Analysis
2.1. Market Introduction
2.2. Executive Summary
2.3. Global Radiopharmaceutical Market Classification
2.4. Market Drivers
2.5. Market Restraints
2.6. Market Opportunity
2.7. Radiopharmaceutical Market: Trends
2.8. Porter’s Five Forces Analysis
2.8.1. Bargaining Power of Suppliers
2.8.2. Bargaining Power of Consumers
2.8.3. Threat of New Entrants
2.8.4. Threat of Substitute Product and Services
2.8.5. Competitive Rivalry within the Industry
2.9. Market Attractiveness Analysis
2.9.1. Market Attractiveness Analysis by Segmentation
2.9.2. Market Attractiveness Analysis by Region
3. Chapter – Global Radiopharmaceutical Market Overview: Quantitative Analysis
4. Chapter – Global Radiopharmaceutical Market Analysis: By Type
5. Chapter – Global Radiopharmaceutical Market Analysis: By Applications Type
6. Chapter – Global Radiopharmaceutical Market Analysis: By End-User Type
7. Chapter – Global Radiopharmaceutical Market Analysis: By Manufacture
………….
9. Chapter – Company Profiles
9.1. Bayer
9.1.1. Financials
9.1.2. Product portfolio
9.1.3. Radiopharmaceutical Market Revenue (USD Million) and Market Share (%), 2014 – 2018
9.1.4. Radiopharmaceutical Sales Market Share (%), 2014 – 2018
9.1.5. Business strategy
9.1.6. Recent developments
9.2. Bayer
9.3. Triad Isotopes
9.4. Lantheus
9.5. GE Healthcare
9.6. Mallinckrodt
9.7. Eli Lilly
9.8. Bracco Imaging
9.9. SIEMENS
9.10. Navidea
9.11. Nordion
9.12. IBA Group
9.13. Jubilant Pharma
9.14. Others.
About Us: Brandessence Market Research and Consulting Pvt. ltd.
Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.
Contact us at: +44-2038074155 or mail us at alan@brandessenceresearch.biz
Website: https://brandessenceresearch.biz
Related Report:
Medical Devices Industry Reports 2019